MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Preladenant

CAS No. : 377727-87-2

MCE 站：Preladenant

产品活性：Preladenant 是一种有效，竞争性的人腺苷 A_2A 受体拮抗剂，K_i 为 1.1 nM，比其他腺苷受体选择性高100倍以上。

研究领域：GPCR/G Protein

作用靶点：Adenosine Receptor

In Vitro: Preladenant also completely antagonizes cAMP in cells expressing the recombinant human A_2A receptor. Preladenant is determined to has K_B values of 1.3 nM at the A_2A receptor; the value is in good agreement with the K_i value determined in the radioligand binding assay. A similar functional assay with A_2B receptor-expressing cells is used to demonstrate selectivity over A_2B receptors. In this assay, the K_B value for Preladenant is 1.2 μM, indicating that Preladenant is 923-fold selective for the A_2A receptor over the A_2B receptor.

In Vivo: Preladenant (1 mg/kg) inhibits L-Dopa-induced behavioral sensitization after repeated daily administration, which suggests a reduced risk of the development of dyskinesias. Preladenant exhibits antidepressant-like profiles in models of behavioral despair, namely the mouse tail suspension test and the mouse and rat forced swim test. Preladenant produces a dose-dependent reduction in parkinsonian scores at doses of 1 mg/kg (min score: 9.0) and 3 mg/kg (min score: 6.5). A subthreshold dose of Preladenant reduces minimum and mean parkinsonian scores in animals treated with 3 mg kg of L-Dopa to 5.25 and 6.88 respectively. A Wilcoxin test is used to compare individual treatments against vehicle. Preladenant (3 mg/kg), L-Dopa (3, 6, and 12 mg/kg), and the combination of Preladenant and L-Dopa (1 or 3 mg/kg+3 mg/kg) are all significantly improved on the minimum parkinsonian score. In addition, both the 12 mg/kg L-Dopa and L-Dopa+Preladenant groups are significantly improved on both minimum and mean parkinsonian scores relative to the 3 mg/kg L-Dopa group.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Clinical Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Drug Repurposing Compound Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  ZM241385  |  CGS 21680 Hydrochloride  |  5'-N-Ethylcarboxamidoadenosine  |  SCH 58261  |  Theophylline  |  Istradefylline  |  Inosine  |  BAY 60-6583  |  MRS 1754  |  Piclidenoson  |  Namodenoson  |  MRS-1191  |  Regadenoson  |  Ticlopidine hydrochloride  |  Aminophylline  |  CGS 15943  |  Diphylline  |  MRS-1706  |  Adenosine 5'-monophosphate monohydrate  |  Capadenoson  |  GR79236  |  N6-(2-Phenylethyl)adenosine  |  Tecadenoson  |  Doxofylline  |  PD 117519  |  APNEA  |  Derenofylline  |  LAS101057  |  N6-Cyclohexyladenosine  |  N6-Cyclopentyladenosine

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。